Update on ARV 110. PSA continues to ... - Advanced Prostate...

Advanced Prostate Cancer

21,016 members26,195 posts

Update on ARV 110. PSA continues to drop

Faith1111 profile image
22 Replies

Hi all, just a small update. My brother had more blood work done and PSA is now 1.7 down from 15 in 4 weeks. 88% decrease. Scans are done at 8 weeks so 3 more weeks to go. He is feeling good. Hopefully his T878A mutation will continue to respond. Will post again after scans with more good news!

Written by
Faith1111 profile image
Faith1111
To view profiles and participate in discussions please or .
Read more about...
22 Replies
Tall_Allen profile image
Tall_Allen

Great news! Thanks for the update.

Mascouche profile image
Mascouche

Sure sounds like great news to me. :) What kind of treatment is your brother doing?

Faith1111 profile image
Faith1111 in reply to Mascouche

My brother is doing the ARV/110 phase two clinical trial at Yale New Haven Hospital in Connecticut. It is very promising for men with certain mutations. It is also working for men without those mutations, at this higher dose level. I will include some information about it for you.

ir.arvinas.com/news-release...

Mascouche profile image
Mascouche in reply to Faith1111

Thank you

Moespy profile image
Moespy in reply to Faith1111

Great news!! Do you know what specific mutation(s) your brother has that they think is helpful with ARV 110?

Faith1111 profile image
Faith1111 in reply to Moespy

Yes he has T878A

Faith1111 profile image
Faith1111 in reply to Faith1111

There are 3 other mutations also showing promise

Moespy profile image
Moespy in reply to Faith1111

Thank you for your response. Do you have the names of the other 3 mutations?

Faith1111 profile image
Faith1111 in reply to Moespy

I

ARV-110 is designed to degrade wild-type AR, as well as forms of AR harboring point mutations, including T878A, H875Y, F877L and M895V, that occur in 5-7 percent of mCRPC patients and confer resistance to abiraterone, enzalutamide, and other anti-androgen therapies. In preclinical models ARV-110 does not degrade the L702H AR mutation or the AR-V7 splice variant, each of which occurs in 3-10 percent and about 30 percent of patients, respectively.

Faith1111 profile image
Faith1111 in reply to Faith1111

nursingcenter.com/

Moespy profile image
Moespy in reply to Faith1111

Thank you so much and best wishes for your brother!

Ramp7 profile image
Ramp7 in reply to Faith1111

I just met with Dr. Petrylak. Considering participating.

Shooter1 profile image
Shooter1

Sounds great..keep us posted

Yadifan profile image
Yadifan

I'm so happy to read this. I've been following your journey and have so hoped you would find answers and hopeful results. Thank you for posting. Wishing you continued success.

Faith1111 profile image
Faith1111 in reply to Yadifan

Thank you so much! I always try to post as much information as I can in hopes that it may help someone else as well. It is why I continue to mention his mutation. He was told by his original oncologist that there was nothing for those mutations. It was after much research that we discovered ARV 110. I’m sure there are men out there that have similar mutations that have no idea about this trial. It is also working for some other mutations as well. Plus I always love sharing positive news!

Curehunter profile image
Curehunter

Very pleased to hear about this. Are there many side effects with this treatment?

Faith1111 profile image
Faith1111 in reply to Curehunter

No it seems pretty safe. He said he feels way better compared to being on Xtandi.

Curehunter profile image
Curehunter

Thank you, that's great

Hope59 profile image
Hope59

That’s so great! So glad to hear it’s working so well for your brother!

Faith1111 profile image
Faith1111 in reply to Hope59

Thank you Hope!!

j-o-h-n profile image
j-o-h-n in reply to Faith1111

Good News for your Bro...... Tell him he's got a good looking sister....oh yeah you can tell her too...

Good Luck, Good Health and Good Humor.

j-o-h-n Tuesday 01/05/2021 10:20 PM EST

Faith1111 profile image
Faith1111

Ha Ha, thank you 😊

You may also like...

My ARV-110 trial update

had blood work, bone scan and CT with contrast to evaluate effectiveness of ARV-110 after 8 weeks...

ARV-110 trial participation update- 4 weeks so far

started the ARV-110 trial 4 weeks ago, my previously rising PSA was at 4.3. It is now 5.8, which...

Started ARV 110 last Monday

to respond well, so far first week of trial is going well going Monday for blood draws praying 🙏...

PSA rising while ALP continues to drop?

the slight rise on PSA. His ALP is still dropping steadily, from 77 in Dec to 61.6 now. Should I...

Exploring options: BAT, Docetaxel (again) ARV 110

been in contact with them and someone from Yale is calling my brother tomorrow. He also has an...